Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer.
Xu J, Liu Y, Li Y, Wang H, Stewart S, Van der Jeught K, Agarwal P, Zhang Y, Liu S, Zhao G, Wan J, Lu X, He X.
Xu J, et al. Among authors: stewart s.
Nat Nanotechnol. 2019 Apr;14(4):388-397. doi: 10.1038/s41565-019-0381-6. Epub 2019 Feb 25.
Nat Nanotechnol. 2019.
PMID: 30804480
Free PMC article.